Business
Notice of Trading Update
hVIVO plc has announced that it will release its trading update for the year ended 31 December 2025 on Thursday, 29 January 2026. The company's Chief Executive Officer and Chief Financial Officer will present the update via the Investor Meet Company platform at 6pm on the same day, offering existing and potential shareholders the opportunity to ask questions both before and during the event. Disclaimer*
About this update from Hvivo Plc
[{"type":"text","content":"\n\n \nhVIVO plc\n(\"hVIVO\", the \"Company\" or the \"Group\")\n \nNotice of Trading Update\n \nhVIVO plc (AIM: HVO), a full-service early phase Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, confirms that it will issue a trading update for the year ended 31 December 2025 on Thursday 29 January 2026.\n \nInvestor presentation\n \nYamin 'Mo' Khan, Chief Executive Officer, and Stephen Pinkerton, Chief Financial Officer, will provide a live presentation relating to the trading update via the Investor Meet Company platform on Thursday 29 January 2026 at 6pm.\n \nThe presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation. \n \nInvestors can sign up to Investor Meet Company for free and add to meet hVIVO here. Investors who already follow hVIVO on the Investor Meet Company platform will automatically be invited.\n \nFor further information please contact:\n \n\n\n\n\nhVIVO plc\n\n\n+44 (0)20 7756 1300\n\n\n\n\nYamin 'Mo' Khan, Chief Executive Officer\nStephen Pinkerton, Chief Financial Officer\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCavendish Capital Markets Limited (Nominated Adviser and Joint Broker)\n\n\n+44 (0)20 7220 0500\n\n\n\n\nGeoff Nash, Callum Davidson\nTrisyia Jamaludin, Harriet Ward\nNigel Birks - Life Science Specialist Sales\nLouise Talbot - Sales\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nPeel Hunt LLP (Joint Broker)\n\n\n+44 (0)20 7418 8900\n\n\n\n\nJames Steel, Dr Christopher Golden\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nDavy (Joint Broker)\n\n\n+353 (0) 1 679 6363\n\n\n\n\nAnthony Farrell, Niall Gilchrist\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nICR Healthcare (Financial PR & IR)\nMary-Jane Elliott / Stephanie Cuthbert / Phillip Marriage / Louis Ashe-Jepson\n \n\n\[email protected]\n\n\n\n\n\n\n\n\n\n\n\n \n \n\n \nNotes to Editors\n \nhVIVO plc (Ticker: HVO) is full-service Contract Research Organisation (CRO) and the global leader in human challenge trials. The company delivers end-to-end clinical development services to a diverse and expanding client base, including seven of the wor...